Shukla N - Search Results

1

Attributes of alternatively activated (M2) macrophages.

Shrivastava R, Shukla N. Shrivastava R, et al. Among authors: shukla n. Life Sci. 2019 May 1;224:222-231. doi: 10.1016/j.lfs.2019.03.062. Epub 2019 Mar 27. Life Sci. 2019. PMID: 30928403 Review.

2

Mechanism of interaction between autophagy and apoptosis in cancer.

Das S, Shukla N, Singh SS, Kushwaha S, Shrivastava R. Das S, et al. Among authors: shukla n. Apoptosis. 2021 Oct;26(9-10):512-533. doi: 10.1007/s10495-021-01687-9. Epub 2021 Sep 12. Apoptosis. 2021. PMID: 34510317 Review.

3

Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.

Burikhanov R, Shrestha-Bhattarai T, Qiu S, Shukla N, Hebbar N, Lele SM, Horbinski C, Rangnekar VM. Burikhanov R, et al. Among authors: shukla n. Cancer Res. 2013 Jan 15;73(2):1011-9. doi: 10.1158/0008-5472.CAN-12-3212. Epub 2012 Nov 30. Cancer Res. 2013. PMID: 23204231 Free PMC article.

4

Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.

Kumar Y, Shukla N, Thacker G, Kapoor I, Lochab S, Bhatt ML, Chattopadhyay N, Sanyal S, Trivedi AK. Kumar Y, et al. Among authors: shukla n. Mol Cancer Res. 2016 Nov;14(11):1097-1109. doi: 10.1158/1541-7786.MCR-16-0138. Epub 2016 Jul 28. Mol Cancer Res. 2016. PMID: 27470268

5

Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor.

Singh M, Rajawat J, Kuldeep J, Shukla N, Mishra DP, Siddiqi MI. Singh M, et al. Among authors: shukla n. J Biomol Struct Dyn. 2022 Nov;40(18):8494-8507. doi: 10.1080/07391102.2021.1913229. Epub 2021 May 5. J Biomol Struct Dyn. 2022. PMID: 33950778

6

Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis.

Burikhanov R, Hebbar N, Noothi SK, Shukla N, Sledziona J, Araujo N, Kudrimoti M, Wang QJ, Watt DS, Welch DR, Maranchie J, Harada A, Rangnekar VM. Burikhanov R, et al. Among authors: shukla n. Cell Rep. 2017 Jan 10;18(2):508-519. doi: 10.1016/j.celrep.2016.12.051. Cell Rep. 2017. PMID: 28076793 Free PMC article.

7

Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking and biological evaluation.

Krishna S, Lakra AD, Shukla N, Khan S, Mishra DP, Ahmed S, Siddiqi MI. Krishna S, et al. Among authors: shukla n. J Biomol Struct Dyn. 2020 Jul;38(11):3280-3295. doi: 10.1080/07391102.2019.1654925. Epub 2019 Sep 9. J Biomol Struct Dyn. 2020. PMID: 31411124

8

Poly(ADP-Ribose) polymerase 1: a therapeutic hope in gynecologic cancers.

Rajawat J, Shukla N, Mishra DP. Rajawat J, et al. Among authors: shukla n. Front Biosci (Schol Ed). 2017 Jun 1;9(3):343-356. doi: 10.2741/s491. Front Biosci (Schol Ed). 2017. PMID: 28410123 Free article. Review.

9

A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.

Hebbar N, Burikhanov R, Shukla N, Qiu S, Zhao Y, Elenitoba-Johnson KSJ, Rangnekar VM. Hebbar N, et al. Among authors: shukla n. Cancer Res. 2017 Aug 1;77(15):4039-4050. doi: 10.1158/0008-5472.CAN-16-1970. Epub 2017 Jun 16. Cancer Res. 2017. PMID: 28625975 Free PMC article.

10

Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.

Rajawat J, Shukla N, Mishra DP. Rajawat J, et al. Among authors: shukla n. Med Res Rev. 2017 Nov;37(6):1461-1491. doi: 10.1002/med.21442. Epub 2017 May 16. Med Res Rev. 2017. PMID: 28510338 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

722 results

Search Page